IP Library › Granted Patent US 10,994,056
Granted Patent B2
US 10,994,056 · App. 15/510,106 · Granted May 4, 2021

Device for fixing biological soft tissue, and method for producing same

Inventors: Toshiji Mukai (Hyogo, JP); Naoko Ikeo (Hyogo, JP); Eisei Gu (Hyogo, JP); Takumi Fukumoto (Hyogo, JP); Hikaru Yabuuchi (Hyogo, JP)
Assignee: NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY
A61L31/00B21C23/002B22D7/005C22C1/02C22C23/00C22C23/04C22F1/06C22F1/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,994,056
App. No.
15/510,106
Granted
May 4, 2021
Kind
B2
Abstract

A device for fixing biological soft tissue is endowed with strength and deformation performance for being used as a device for coupling biological soft tissue that has been cut or separated due to an incision or the like during a surgical procedure, and is completely degraded in vivo and discharged after adhesion of the soft tissue or after healing of the incision tissue. The device is composed of a ternary Mg alloy material of Mg—Ca—Zn. In the Mg alloy material, the Ca and Zn are contained within the solid-solubility limit with respect to the Mg. The remainder is composed of Mg and unavoidable impurities. The Zn content is 0.5 at % or less. The Ca and Zn content has a relationship of Ca:Zn=1:x (where x is 1 to 3) by atom ratio. The crystal grain structure is equiaxed, the crystal grain size according to linear intercept being 30 to 250 μm.

Claims (29)

1. A device for fixing biological soft tissue comprising a ternary Mg alloy material of Mg—Ca—Zn, wherein:

the ternary Mg alloy material contains Ca and Zn within the solid-solubility limit with respect to Mg,

the remainder comprises Mg and unavoidable impurities, a Zn content is more than zero and equal to or less than 0.5 atom %,

Ca and Zn content levels are such that Ca:Zn=1:x (where x is 1 to 3) by atomic ratio, and

a crystal grain structure is equiaxed and comprises a plurality of crystal grains having an average crystal grain size of 20 to 250 μm.

2. The device for fixing biological soft tissue according to claim 1 , wherein the Zn content is from 0.2 atom % to 0.4 atom %, the Ca and Zn content levels are such that Ca:Zn=1:x (where x is 2 to 3) by atomic ratio.

3. The device for fixing biological soft tissue according to claim 1 , wherein:

crystal grain boundaries of the plurality of crystal grains have crystal misorientation of 15° or greater,

at least one of the plurality of crystal grains includes crystal subgrains, and

crystal subgrain boundaries have crystal misorientation of from 3° to less than 15°, which are boundaries that divide the crystal grain structure when a true strain of at least 0.123 is applied by deformation.

4. The device for fixing biological soft tissue according to claim 2 , wherein:

crystal grain boundaries of the plurality of crystal grains have crystal misorientation of 150 or greater,

at least one of the plurality of crystal grains includes crystal subgrains, and

crystal subgrain boundaries have crystal misorientation of from 3° to less than 15°, which are boundaries that divide the crystal grain structure when a true strain of at least 0.123 is applied by deformation.

5. The device for fixing biological soft tissue according to claim 1 , wherein a biodegradation residual ratio is 50-92% four weeks after implantation and an amount of gas generated in association with degradation is not more than twice a volume of a space formed during bioimplantation.

6. The device for fixing biological soft tissue according to claim 2 , wherein a biodegradation residual ratio is 50-92% four weeks after implantation and an amount of gas generated in association with degradation is not more than twice a volume of a space formed during bioimplantation.

7. The device for fixing biological soft tissue according to claim 3 , wherein a biodegradation residual ratio is 50-92% four weeks after implantation and an amount of gas generated in association with degradation is not more than twice a volume of a space formed during bioimplantation.

8. The device for fixing biological soft tissue according to claim 4 , wherein a biodegradation residual ratio is 50-92% four weeks after implantation and an amount of gas generated in association with degradation is not more than twice a volume of a space formed during bioimplantation.

9. The device for fixing biological soft tissue according to claim 1 , wherein the ternary Mg alloy material consists of Mg, Ca and Zn and the unavoidable impurities.

10. The device for fixing biological soft tissue according to claim 1 , wherein the device is a surgical clip or staple.

11. The device for fixing biological soft tissue according to claim 10 , wherein the surgical clip or staple includes two ends and at least one curved portion disposed between the two ends.

12. The device for fixing biological soft tissue according to claim 1 , wherein:

crystal grain boundaries of the plurality of crystal grains have crystal misorientation of 15° or greater,

at least one of the plurality of crystal grains includes crystal subgrains, and

crystal subgrain boundaries have crystal misorientation of from 3° to less than 15°, which are boundaries that divide the crystal grain structure when a true strain of at least 0.193 is applied by deformation.

13. The device for fixing biological soft tissue according to claim 2 , wherein:

crystal grain boundaries of the plurality of crystal grains have crystal misorientation of 15° or greater,

at least one of the plurality of crystal grains includes crystal subgrains, and

crystal subgrain boundaries have crystal misorientation of from 3° to less than 15°, which are boundaries that divide the crystal grain structure when a true strain of at least 0.193 is applied by deformation.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2017
From: MUKAI, TOSHIJI; IKEO, NAOKO; GU, EISEI; FUKUMOTO, TAKUMI; YABUUCHI, HIKARU
To: NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY
Reel/Frame 041530/0758 →
Priority Claims (2)
JP JP2014-183716 · Sep 9, 2014 · national
JP JP2015-050101 · Mar 12, 2015 · national
Continuity (1)
Related Publication 20170258968A1 · Sep 14, 2017
Cited By (1)
US 12,188,108